Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report

Saved in:
Bibliographic Details
Published in:Acta oncologica (Stockholm, Sweden) Sweden), 2018, Vol.57 (5), p.705-708
Main Authors: Naqash, Abdul Rafeh, Yang, Li V, Sanderlin, Edward J, Atwell, Druid C, Walker, Paul R
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1651-226X
DOI:10.1080/0284186X.2017.1406668